Conestoga Capital Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-6,939
| Closed | -$212K | – | 118 |
|
|
2016
Q2 | $212K | Sell |
6,939
-400
| -5% | -$12.2K | 0.02% | 110 |
|
|
2016
Q1 | $275K | Sell |
7,339
-3,565
| -33% | -$134K | 0.02% | 91 |
|
|
2015
Q4 | $471K | Sell |
10,904
-1,546
| -12% | -$66.8K | 0.04% | 69 |
|
|
2015
Q3 | $467K | Hold |
12,450
| – | – | 0.04% | 66 |
|
|
2015
Q2 | $423K | Buy |
12,450
+156
| +1% | +$5.3K | 0.03% | 74 |
|
|
2015
Q1 | $435K | Sell |
12,294
-156
| -1% | -$5.52K | 0.03% | 76 |
|
|
2014
Q4 | $424K | Hold |
12,450
| – | – | 0.03% | 81 |
|
|
2014
Q3 | $480K | Sell |
12,450
-3,600
| -22% | -$139K | 0.04% | 63 |
|
|
2014
Q2 | $625K | Hold |
16,050
| – | – | 0.04% | 56 |
|
|
2014
Q1 | $549K | Sell |
16,050
-3,030
| -16% | -$104K | 0.03% | 72 |
|
|
2013
Q4 | $400K | Buy |
19,080
+1,900
| +11% | +$39.8K | 0.03% | 85 |
|
|
2013
Q3 | $404K | Sell |
17,180
-550
| -3% | -$12.9K | 0.03% | 77 |
|
|
2013
Q2 | $476K | Buy |
+17,730
| New | +$476K | 0.05% | 65 |
|